Schroeder R E, Doria-Medina C L, Das U G, Sivitz W I, Devaskar S U
Department of Pediatrics, St. Louis University School of Medicine, Missouri, USA.
Pediatr Res. 1997 Jan;41(1):11-9. doi: 10.1203/00006450-199701000-00002.
We investigated the effect of streptozotocin-induced short-term maternal diabetes upon fetal rat myocardial and skeletal muscle glucose transporter Glut 1 (basal form) and Glut 4 (insulin-responsive form) protein concentrations by Western blot analysis. In the severely diabetic group (SEVERE-D, n = 17), a 3-fold increase in maternal and fetal glucose concentrations (p < 0.01) was associated with a 3-fold decline in maternal (p < 0.01) with no change in fetal insulin levels when compared with the streptozotocin-treated nondiabetic (n = 10) and vehicle-treated control (control, n = 14) groups. These changes in the SEVERE-D group when compared with controls were associated with a 30 and 65% decline, respectively, in fetal myocardial and skeletal muscle (forelimb and hind limb) Glut 1 protein concentrations. The fetal myocardium also demonstrated a 45% decline in Glut 4 protein levels. Fetal skeletal muscle Glut 4 protein, which was expressed only at very low levels in controls showed no change in SEVERE-D. Immunohistochemical analysis revealed a myocyte-plasma membrane association of Glut 1 and an intracellular Glut 4 distribution in the fetal myocardium and skeletal muscle. No Glut 1 immunoreactivity was noted in either the fetal myocardial or skeletal muscle perineural sheaths, blood vessels, or the entrapped fetal red blood cells. This subcellular localization pattern was unaltered in all three treatment groups. We conclude that maternal diabetes causing fetal hyperglycemia with normoinsulinemia suppresses fetal myocardial Glut 1 and Glut 4 and fetal skeletal muscle Glut 1. The decline in the plasma membrane associated Glut 1 concentrations may serve a protective function by reducing the glucose transport rate into fetal myocardial and skeletal muscle cells, which otherwise could be vulnerable to high circulating glucose. The in-utero maternal diabetes induced decrease in fetal myocardial intracellular-Glut 4 concentration could herald the emergence of insulin resistance.
我们通过蛋白质免疫印迹分析,研究了链脲佐菌素诱导的短期母体糖尿病对胎鼠心肌和骨骼肌葡萄糖转运蛋白Glut 1(基础形式)和Glut 4(胰岛素反应形式)蛋白浓度的影响。与链脲佐菌素处理的非糖尿病组(n = 10)和溶剂处理的对照组(对照组,n = 14)相比,在重度糖尿病组(SEVERE-D,n = 17)中,母体和胎儿血糖浓度增加了3倍(p < 0.01),母体血糖浓度下降了3倍(p < 0.01),而胎儿胰岛素水平没有变化。与对照组相比,SEVERE-D组的这些变化分别与胎儿心肌和骨骼肌(前肢和后肢)Glut 1蛋白浓度下降30%和65%有关。胎儿心肌中Glut 4蛋白水平也下降了45%。胎儿骨骼肌Glut 4蛋白在对照组中仅以非常低的水平表达,在SEVERE-D组中没有变化。免疫组织化学分析显示,在胎儿心肌和骨骼肌中,Glut 1与肌细胞质膜相关,Glut 4分布在细胞内。在胎儿心肌或骨骼肌的神经周围鞘、血管或被困的胎儿红细胞中均未发现Glut 1免疫反应性。这种亚细胞定位模式在所有三个治疗组中均未改变。我们得出结论,母体糖尿病导致胎儿高血糖伴正常胰岛素血症会抑制胎儿心肌中的Glut 1和Glut 4以及胎儿骨骼肌中的Glut 1。质膜相关Glut 1浓度的下降可能通过降低葡萄糖向胎儿心肌和骨骼肌细胞的转运速率起到保护作用,否则这些细胞可能易受高循环葡萄糖的影响。子宫内母体糖尿病诱导的胎儿心肌细胞内Glut 4浓度降低可能预示着胰岛素抵抗的出现。